Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.
about
Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamasesIn vitro evaluation of Ro 13-9904AmpD, essential for both beta-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase.Bacterial antibiotic resistance before and after clinical application in the United States.In vitro activity of U-76,252 (CS-807), a new oral cephalosporinContribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.Therapy of lower respiratory tract infections with moxalactam.Cefotaxime therapy of serious bacterial infection in adults.Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.Development of resistance to cephalosporins in clinical strains of Citrobacter spp.SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.In vitro response of Enterobacter to ampicillin.The changing ecology of hospital bacteria and the selective role of cephalosporinsComparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamase.Cefotiam susceptibility testing criteriaCefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae.Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.Common mechanism of ampC beta-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene.Transfer of the chromosomal bla gene from Enterobacter cloacae to Escherichia coli by RP4::mini-MuMoxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.Dissociated resistance among cephalosporins.Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.Antibacterial activity of cefoperazone alone and in combination against cephalosporinase-producing Enterobacter cloacae.In vitro activity of LY127935.Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.What do beta-lactamases mean for clinical efficacy?Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
P2860
Q24597685-170E25FB-85B2-43B2-8684-C5C6F27F189AQ33734775-CC81349A-BF18-4339-8481-56C380CE6418Q34313267-BFC985C3-49E9-4576-B94F-E140B9E5A3B3Q35119490-F2C5088A-1C14-40E5-96FF-09FD14CFB8E6Q35314616-3411422E-8289-4555-8CC0-2E7EDDBF5037Q35542647-7E403051-3C6E-498B-AA4C-C9279AB7CC85Q35669739-66939A7A-CE9D-4E15-AF51-01C46C063A72Q35674328-87F4600D-1B9C-4ED5-A72F-EEB795EFFC99Q35675266-1ED061FA-5F3C-4E92-BA3C-32F4457A3631Q35712440-E72D8A1E-9A78-46BC-B212-90331301C9E2Q35759876-808CA66E-7F58-46AC-AB20-3C75D3FA5B08Q36469650-2AB91459-0514-4D35-A78C-213B961A4D17Q36484457-D6CBEB61-86EA-42E5-A972-5BA360AD3BFBQ36505127-E4B0D64D-A35F-4236-88A9-CD6E09C67C13Q37114985-AA14BFBC-8143-4D2D-8EEE-D06184C6EEF9Q37283624-364372BC-D545-4159-BE02-2298DE7AEB03Q37291928-CFE9678E-07AB-434F-9A2A-C7BA2B606147Q37329147-96086965-5B6B-40FF-BEE3-9C86AAF6F389Q37329295-BCE9A20A-9727-4E78-956F-E24FDDB411F1Q39681275-885ECC96-8A71-4A42-8E97-1A93B122407FQ39827699-953276E4-9D90-41ED-95E7-2D3BE33579CDQ39854724-A478E78F-9E8F-49C8-9CE9-24C6D09D4954Q39955800-5B1A9ABD-2C92-4016-A160-9DA690556309Q39967218-A85FE43C-36EC-4023-B00E-DF0005157BF4Q40281987-42183778-1309-4F78-849F-ED592DE76FE5Q40616592-167B7B2C-261F-4AAC-BDB0-B8CA9C2E139BQ40619746-C573B432-2F50-4336-9514-7565B2A9CEA1Q40620280-4488F5D8-F8BF-468B-9376-04AE04736125Q40620348-1A4D5A88-C1B1-4C2A-B1DE-8289F94BD198Q41136367-43F6F1C5-148B-4854-A91E-A3E92F3359CDQ42032332-E03E6387-01BB-4C1F-8DD6-208A140A2128Q42037068-4A5D5D58-3028-41C2-81F1-F56227F706DCQ42705399-B3BE5D5D-B67B-4CE9-9E53-06DAA0A0DD9EQ50212297-6D8AEDD2-FAB0-42A2-85AF-AD72E444E6D8Q54543524-2364AE89-DCE7-4275-8B2A-781490E7686A
P2860
Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Susceptibility of Enterobacter ...... h mutation rate to resistance.
@en
type
label
Susceptibility of Enterobacter ...... h mutation rate to resistance.
@en
prefLabel
Susceptibility of Enterobacter ...... h mutation rate to resistance.
@en
P2860
P356
P1476
Susceptibility of Enterobacter ...... h mutation rate to resistance.
@en
P2093
Findell CM
Sherris JC
P2860
P304
P356
10.1128/AAC.9.6.970
P407
P577
1976-06-01T00:00:00Z